Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | +5.77% | -4.31% | +1.83% |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.83% | 196M | |
+28.87% | 49.18B | |
+0.89% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.30% | 26.09B | |
-22.53% | 18.71B | |
+8.16% | 13.26B | |
+32.17% | 12.32B | |
-0.45% | 11.99B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- Lineage Cell Therapeutics : Chardan Suspends Coverage on Lineage Cell Therapeutics at Buy Rating With $4 Price Target